South & Central America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product, Dosage Form, Type, and Distribution Channel

Description

List of Tables

The South & Central America dry eye products market was valued at US$ 255.13 million in 2023 and is expected to reach US$ 316.84 million by 2031; it is estimated to register a CAGR of 2.7% from 2023 to 2031.

Increasing Initiatives for Eye Care Awareness Fuel South & Central America Dry Eye Products Market

In recent years, various initiatives have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. ABP focuses on moderate to severe vision damage caused by glaucoma and retinal conditions that are responsible for a large proportion of preventable blindness.

The International Agency for the Prevention of Blindness (IAPB) launched the global campaign named "Love Your Eyes" in 2022 to raise awareness of the socioeconomic importance of eye health. The campaign calls upon governments and global institutions to support eye health. The IAPB emphasizes programs and initiatives in India and the world, which promptly focus on offering accessible, available, and affordable eye care. The "Love Your Eyes" program also calls for regulation changes and funding to make eye care accessible, available, and affordable by 2030.

Thus, increasing funds for eyecare research and rising initiatives to spread awareness about eye care are likely to create new opportunities in the dry eye product market in the coming years.

South & Central America Dry Eye Products Market Overview

The dry eye products market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil holds a major market share in this region, and it is further expected to record the highest CAGR during the forecast period. Market growth in the region can be attributed to the increasing prevalence of dry eye disease, surging healthcare expenditure, rising prevalence of diabetes, and ongoing research studies on eye diseases. Brazil has the largest population among all countries in South & Central America. According to the study "Brazil facing ageing population challenges," published in November 2023, the number of people aged 65 or more has increased by 57% from 2010 to 2022, reaching 22.2 million in 2022 from 14.1 million in 2010. Population aging can be associated with the burgeoning demand for dry eye products in this country. Further, the study "Prevalence and associated risk factors for dry eye disease among Brazilian undergraduate students," published in November 2021, was conducted to evaluate the prevalence of dry eye disease in young students in Brazil. The study concluded that dry eye disease and its associated risk factors are more prevalent in undergraduate students as compared to people over 40 years of age in the country. Thus, increasing eye health awareness and surging prevalence of dry eye disease are creating a positive environment for the growth of the dry eye disease products market in the country.

South & Central America Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Dry Eye Products Market Segmentation

The South & Central America dry eye products market is categorized into product, dosage form, type, distribution channel, and country.

Based on product, the South & Central America dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest South & Central America dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the South & Central America dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest South & Central America dry eye products market share in 2023.

By type, the South & Central America dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger South & Central America dry eye products market share in 2023.

Based on distribution channel, the South & Central America dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest South & Central America dry eye products market share in 2023.

Based on country, the South & Central America dry eye products market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America dry eye products market share in 2023.

Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Farmigea SpA, and Alcon AG are some of the leading companies operating in the South & Central America dry eye products market.

Product Code: TIPRE00016265

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Dry Eye Products Market - Key Market Dynamics

4.1 South & Central America Dry Eye Products Market - Key Market Dynamics
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Dry Eye
- 4.2.2 Upsurge in Geriatric Population
4.3 Market Restraints
- 4.3.1 Side Effects of Eye Drops and Product Recalls
4.4 Market Opportunities
- 4.4.1 Increasing Initiatives for Eye Care Awareness
4.5 Future Trends
- 4.5.1 Ongoing Research and Growing Pipeline for Dry Eye Products
4.6 Impact of Drivers and Restraints:

5. Dry Eye Products Market - South & Central America Analysis

5.1 South & Central America Dry Eye Products Market Revenue (US$ Million), 2021-2031

6. South & Central America Dry Eye Products Market Analysis - by Product

6.1 Overview
6.2 Artificial Tears
- 6.2.1 Overview
- 6.2.2 Artificial Tears: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Anti-Inflammatory Drugs
- 6.3.1 Overview
- 6.3.2 Anti-Inflammatory Drugs: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  - 6.3.2.1 South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
6.4 Punctal Plugs
- 6.4.1 Overview
- 6.4.2 Punctal Plugs: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  - 6.4.2.1 South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
6.5 Secretagogues
- 6.5.1 Overview
- 6.5.2 Secretagogues: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.6 Oral Omega Supplements
- 6.6.1 Overview
- 6.6.2 Oral Omega Supplements: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

7. South & Central America Dry Eye Products Market Analysis - by Dosage Form

7.1 Overview
7.2 Eye Drops
- 7.2.1 Overview
- 7.2.2 Eye Drops: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Gels
- 7.3.1 Overview
- 7.3.2 Gels: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Capsules and Tablets
- 7.4.1 Overview
- 7.4.2 Capsules and Tablets: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Dry Eye Products Market Analysis - by Type

8.1 Overview
8.2 OTC
- 8.2.1 Overview
- 8.2.2 OTC: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Prescription
- 8.3.1 Overview
- 8.3.2 Prescription: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

9. South & Central America Dry Eye Products Market Analysis - by Distribution Channel

9.1 Overview
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Online Pharmacies
- 9.4.1 Overview
- 9.4.2 Online Pharmacies: South & Central America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

10. South & Central America Dry Eye Products Market - Country Analysis

10.1 South and Central America
- 10.1.1 South and Central America: Dry Eye Products Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Brazil: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 Brazil: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.1.3 Brazil: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.1.3.1 Brazil: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.1.3.2 Brazil: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.1.4 Brazil: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.1.5 Brazil: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.1.6 Brazil: Dry Eye Products Market Breakdown, by Distribution Channel
  - 10.1.1.2 Argentina: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Argentina: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.2.3 Argentina: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.2.3.1 Argentina: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.2.3.2 Argentina: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.2.4 Argentina: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.2.5 Argentina: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.2.6 Argentina: Dry Eye Products Market Breakdown, by Distribution Channel
  - 10.1.1.3 Rest of South and Central America: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Rest of South and Central America: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.3.3 Rest of South and Central America: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.3.3.1 Rest of South and Central America: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.3.3.2 Rest of South and Central America: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.3.4 Rest of South and Central America: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.3.5 Rest of South and Central America: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.3.6 Rest of South and Central America: Dry Eye Products Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Dry Eye Products Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Santen Pharmaceutical Co Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Johnson & Johnson
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 OASIS Medical
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 URSAPHARM Arzneimittel GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 OCuSOFT Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bausch Health Companies Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 AbbVie Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Farmigea SpA
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Alcon AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms